Skip to main content
Erschienen in: Angiogenesis 2/2016

09.01.2016 | Original Paper

Hypoxia paradoxically inhibits the angiogenic response of isolated vessel explants while inducing overexpression of vascular endothelial growth factor

verfasst von: Alfred C. Aplin, Roberto F. Nicosia

Erschienen in: Angiogenesis | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

This study was designed to investigate how changes in O2 levels affected angiogenesis in vascular organ culture. Although hypoxia is a potent inducer of angiogenesis, aortic rings cultured in collagen paradoxically failed to produce an angiogenic response in 1–4 % O2. Additionally, aortic neovessels preformed in atmospheric O2 lost pericytes and regressed at a faster rate than control when exposed to hypoxia. Aortic explants remained viable in hypoxia and produced an angiogenic response when returned to atmospheric O2. Hypoxic aortic rings were unresponsive to VEGF, while increased oxygenation of the system dose-dependently enhanced VEGF-induced angiogenesis. Hypoxia-induced refractoriness to angiogenic stimulation was not restricted to the aorta because similar results were obtained with vena cava explants or isolated endothelial cells. Unlike endothelial cells, aorta-derived mural cells were unaffected by hypoxia. Hypoxia downregulated expression in aortic explants of key signaling molecules including VEGFR2, NRP1 and Prkc-beta while upregulating expression of VEGFR1. Medium conditioned by hypoxic cultures exhibited angiostatic and anti-VEGF activities likely mediated by sVEGFr1. Hypoxia reduced expression of VEGFR1 and VEGFR2 in endothelial cells while upregulating VEGFR1 in macrophages and VEGF in both macrophages and mural cells. Thus, changes in O2 levels profoundly affect the endothelial response to angiogenic stimuli. These results suggest that hypoxia-induced angiogenesis is fine-tuned by complex regulatory mechanisms involving not only production of angiogenic factors including VEGF but also differential regulation of VEGFR expression in different cell types and production of inhibitors of VEGF function such as sVEGFR1.
Literatur
1.
Zurück zum Zitat Fisher SA, Burggren WW (2007) Role of hypoxia in the evolution and development of the cardiovascular system. Antioxid Redox Signal 9:1339–1352CrossRefPubMed Fisher SA, Burggren WW (2007) Role of hypoxia in the evolution and development of the cardiovascular system. Antioxid Redox Signal 9:1339–1352CrossRefPubMed
2.
Zurück zum Zitat Monahan-Earley R, Dvorak AM, Aird WC (2013) Evolutionary origins of the blood vascular system and endothelium. J Thromb Haemost 11(Suppl 1):46–66CrossRefPubMed Monahan-Earley R, Dvorak AM, Aird WC (2013) Evolutionary origins of the blood vascular system and endothelium. J Thromb Haemost 11(Suppl 1):46–66CrossRefPubMed
3.
5.
Zurück zum Zitat Dor Y, Porat R, Keshet E (2001) Vascular endothelial growth factor and vascular adjustments to perturbations in oxygen homeostasis. Am J Physiol Cell Physiol 280:C1367–C1374PubMed Dor Y, Porat R, Keshet E (2001) Vascular endothelial growth factor and vascular adjustments to perturbations in oxygen homeostasis. Am J Physiol Cell Physiol 280:C1367–C1374PubMed
6.
Zurück zum Zitat Rey S, Semenza GL (2010) Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling. Cardiovasc Res 86:236–242CrossRefPubMedPubMedCentral Rey S, Semenza GL (2010) Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling. Cardiovasc Res 86:236–242CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Imtiyaz HZ, Simon MC (2010) Hypoxia-inducible factors as essential regulators of inflammation. Curr Top Microbiol Immunol 345:105–120PubMedPubMedCentral Imtiyaz HZ, Simon MC (2010) Hypoxia-inducible factors as essential regulators of inflammation. Curr Top Microbiol Immunol 345:105–120PubMedPubMedCentral
8.
Zurück zum Zitat Carreau A, Hafny-Rahbi B, Matejuk A, Grillon C, Kieda C (2011) Why is the partial oxygen pressure of human tissues a crucial parameter? small molecules and hypoxia. J Cell Mol Med 15:1239–1253CrossRefPubMedPubMedCentral Carreau A, Hafny-Rahbi B, Matejuk A, Grillon C, Kieda C (2011) Why is the partial oxygen pressure of human tissues a crucial parameter? small molecules and hypoxia. J Cell Mol Med 15:1239–1253CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Simons M, Alitalo K, Annex BH, Augustin HG, Beam C et al (2015) State-of-the-art methods for evaluation of angiogenesis and tissue vascularization: a scientific statement from the American Heart Association. Circ Res 116:e99–e132CrossRefPubMed Simons M, Alitalo K, Annex BH, Augustin HG, Beam C et al (2015) State-of-the-art methods for evaluation of angiogenesis and tissue vascularization: a scientific statement from the American Heart Association. Circ Res 116:e99–e132CrossRefPubMed
10.
Zurück zum Zitat Slevin M, Krupinski J, Badimon L (2009) Controlling the angiogenic switch in developing atherosclerotic plaques: possible targets for therapeutic intervention. J Angiogenes Res 1:4CrossRefPubMedPubMedCentral Slevin M, Krupinski J, Badimon L (2009) Controlling the angiogenic switch in developing atherosclerotic plaques: possible targets for therapeutic intervention. J Angiogenes Res 1:4CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Baluk P, Hashizume H, McDonald DM (2005) Cellular abnormalities of blood vessels as targets in cancer. Curr Opin Genet Dev 15:102–111CrossRefPubMed Baluk P, Hashizume H, McDonald DM (2005) Cellular abnormalities of blood vessels as targets in cancer. Curr Opin Genet Dev 15:102–111CrossRefPubMed
13.
Zurück zum Zitat Nicosia RF, Zhu WH, Fogel E, Howson KM, Aplin AC (2005) A new ex vivo model to study venous angiogenesis and arterio-venous anastomosis formation. J Vasc Res 42:111–119CrossRefPubMed Nicosia RF, Zhu WH, Fogel E, Howson KM, Aplin AC (2005) A new ex vivo model to study venous angiogenesis and arterio-venous anastomosis formation. J Vasc Res 42:111–119CrossRefPubMed
14.
Zurück zum Zitat Aplin AC, Fogel E, Zorzi P, Nicosia RF (2008) The aortic ring model of angiogenesis. Methods Enzymol 443:119–136CrossRefPubMed Aplin AC, Fogel E, Zorzi P, Nicosia RF (2008) The aortic ring model of angiogenesis. Methods Enzymol 443:119–136CrossRefPubMed
15.
Zurück zum Zitat Aplin AC, Fogel E, Nicosia RF (2010) MCP-1 promotes mural cell recruitment during angiogenesis in the aortic ring model. Angiogenesis 13:219–226CrossRefPubMedPubMedCentral Aplin AC, Fogel E, Nicosia RF (2010) MCP-1 promotes mural cell recruitment during angiogenesis in the aortic ring model. Angiogenesis 13:219–226CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Nicosia RF, Villaschi S, Smith M (1994) Isolation and characterization of vasoformative endothelial cells from the rat aorta. In Vitro Cell Dev Biol Anim 30A:394–399CrossRefPubMed Nicosia RF, Villaschi S, Smith M (1994) Isolation and characterization of vasoformative endothelial cells from the rat aorta. In Vitro Cell Dev Biol Anim 30A:394–399CrossRefPubMed
17.
Zurück zum Zitat Villaschi S, Nicosia RF, Smith MR (1994) Isolation of a morphologically and functionally distinct smooth muscle cell type from the intimal aspect of the normal rat aorta: evidence for smooth muscle cell heterogeneity. In Vitro Cell Dev Biol Anim 30A:589–595CrossRefPubMed Villaschi S, Nicosia RF, Smith MR (1994) Isolation of a morphologically and functionally distinct smooth muscle cell type from the intimal aspect of the normal rat aorta: evidence for smooth muscle cell heterogeneity. In Vitro Cell Dev Biol Anim 30A:589–595CrossRefPubMed
18.
Zurück zum Zitat Nicosia RF, Villaschi S (1995) Rat aortic smooth muscle cells become pericytes during angiogenesis in vitro. Lab Invest 73:658–666PubMed Nicosia RF, Villaschi S (1995) Rat aortic smooth muscle cells become pericytes during angiogenesis in vitro. Lab Invest 73:658–666PubMed
19.
Zurück zum Zitat Ligresti G, Aplin AC, Zorzi P, Morishita A, Nicosia RF (2011) Macrophage-derived tumor necrosis factor-alpha is an early component of the molecular cascade leading to angiogenesis in response to aortic injury. Arterioscler Thromb Vasc Biol 31:1151–1159CrossRefPubMedPubMedCentral Ligresti G, Aplin AC, Zorzi P, Morishita A, Nicosia RF (2011) Macrophage-derived tumor necrosis factor-alpha is an early component of the molecular cascade leading to angiogenesis in response to aortic injury. Arterioscler Thromb Vasc Biol 31:1151–1159CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Aplin AC, Gelati M, Fogel E, Carnevale E, Nicosia RF (2006) Angiopoietin-1 and vascular endothelial growth factor induce expression of inflammatory cytokines before angiogenesis. Physiol Genomics 27:20–28CrossRefPubMed Aplin AC, Gelati M, Fogel E, Carnevale E, Nicosia RF (2006) Angiopoietin-1 and vascular endothelial growth factor induce expression of inflammatory cytokines before angiogenesis. Physiol Genomics 27:20–28CrossRefPubMed
21.
Zurück zum Zitat Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402–408CrossRefPubMed Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402–408CrossRefPubMed
22.
Zurück zum Zitat Hielscher A, Gerecht S (2015) Hypoxia and free radicals: role in tumor progression and the use of engineering-based platforms to address these relationships. Free Radic Biol Med 79:281–291CrossRefPubMed Hielscher A, Gerecht S (2015) Hypoxia and free radicals: role in tumor progression and the use of engineering-based platforms to address these relationships. Free Radic Biol Med 79:281–291CrossRefPubMed
23.
Zurück zum Zitat Salisbury D, Bronas U (2015) Reactive oxygen and nitrogen species: impact on endothelial dysfunction. Nurs Res 64:53–66CrossRefPubMed Salisbury D, Bronas U (2015) Reactive oxygen and nitrogen species: impact on endothelial dysfunction. Nurs Res 64:53–66CrossRefPubMed
24.
Zurück zum Zitat Rushworth GF, Megson IL (2014) Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits. Pharmacol Ther 141:150–159CrossRefPubMed Rushworth GF, Megson IL (2014) Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits. Pharmacol Ther 141:150–159CrossRefPubMed
25.
Zurück zum Zitat Nicosia RF, Nicosia SV, Smith M (1994) Vascular endothelial growth factor, platelet-derived growth factor, and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro. Am J Pathol 145:1023–1029PubMedPubMedCentral Nicosia RF, Nicosia SV, Smith M (1994) Vascular endothelial growth factor, platelet-derived growth factor, and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro. Am J Pathol 145:1023–1029PubMedPubMedCentral
26.
Zurück zum Zitat Nicosia RF, Lin YJ, Hazelton D, Qian X (1997) Endogenous regulation of angiogenesis in the rat aorta model: role of vascular endothelial growth factor. Am J Pathol 151:1379–1386PubMedPubMedCentral Nicosia RF, Lin YJ, Hazelton D, Qian X (1997) Endogenous regulation of angiogenesis in the rat aorta model: role of vascular endothelial growth factor. Am J Pathol 151:1379–1386PubMedPubMedCentral
27.
28.
Zurück zum Zitat Wang J, Shi M, Xi Y, Gao L, Zhang G et al (2015) Recombinant human vascular endothelial growth factor receptor 1 effectively inhibits angiogenesis in vivo. Mol Med Rep 11:3432–3438PubMed Wang J, Shi M, Xi Y, Gao L, Zhang G et al (2015) Recombinant human vascular endothelial growth factor receptor 1 effectively inhibits angiogenesis in vivo. Mol Med Rep 11:3432–3438PubMed
29.
Zurück zum Zitat Herzog B, Pellet-Many C, Britton G, Hartzoulakis B, Zachary IC (2011) VEGF binding to NRP1 is essential for VEGF stimulation of endothelial cell migration, complex formation between NRP1 and VEGFR2, and signaling via FAK Tyr407 phosphorylation. Mol Biol Cell 22:2766–2776CrossRefPubMedPubMedCentral Herzog B, Pellet-Many C, Britton G, Hartzoulakis B, Zachary IC (2011) VEGF binding to NRP1 is essential for VEGF stimulation of endothelial cell migration, complex formation between NRP1 and VEGFR2, and signaling via FAK Tyr407 phosphorylation. Mol Biol Cell 22:2766–2776CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Suzuma K, Takahara N, Suzuma I, Isshiki K, Ueki K et al (2002) Characterization of protein kinase C beta isoform’s action on retinoblastoma protein phosphorylation, vascular endothelial growth factor-induced endothelial cell proliferation, and retinal neovascularization. Proc Natl Acad Sci USA 99:721–726CrossRefPubMedPubMedCentral Suzuma K, Takahara N, Suzuma I, Isshiki K, Ueki K et al (2002) Characterization of protein kinase C beta isoform’s action on retinoblastoma protein phosphorylation, vascular endothelial growth factor-induced endothelial cell proliferation, and retinal neovascularization. Proc Natl Acad Sci USA 99:721–726CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Marsch E, Sluimer JC, Daemen MJ (2013) Hypoxia in atherosclerosis and inflammation. Curr Opin Lipidol 24:393–400PubMed Marsch E, Sluimer JC, Daemen MJ (2013) Hypoxia in atherosclerosis and inflammation. Curr Opin Lipidol 24:393–400PubMed
33.
Zurück zum Zitat Virmani R, Kolodgie FD, Burke AP, Finn AV, Gold HK et al (2005) Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 25:2054–2061CrossRefPubMed Virmani R, Kolodgie FD, Burke AP, Finn AV, Gold HK et al (2005) Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 25:2054–2061CrossRefPubMed
34.
Zurück zum Zitat Kida Y, Tchao BN, Yamaguchi I (2014) Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease. Pediatr Nephrol 29:333–342CrossRefPubMedPubMedCentral Kida Y, Tchao BN, Yamaguchi I (2014) Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease. Pediatr Nephrol 29:333–342CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Schreml S, Szeimies RM, Prantl L, Karrer S, Landthaler M et al (2010) Oxygen in acute and chronic wound healing. Br J Dermatol 163:257–268CrossRefPubMed Schreml S, Szeimies RM, Prantl L, Karrer S, Landthaler M et al (2010) Oxygen in acute and chronic wound healing. Br J Dermatol 163:257–268CrossRefPubMed
37.
38.
Zurück zum Zitat Siegel ME, Giargiana FA Jr, Rhodes BA, Williams GM, Wagner HN Jr (1975) Perfusion of ischemic ulcers of the extremity: a prognostic indicator of healing. Arch Surg 110:265–268CrossRefPubMed Siegel ME, Giargiana FA Jr, Rhodes BA, Williams GM, Wagner HN Jr (1975) Perfusion of ischemic ulcers of the extremity: a prognostic indicator of healing. Arch Surg 110:265–268CrossRefPubMed
40.
Zurück zum Zitat Senger DR, Perruzzi CA, Feder J, Dvorak HF (1986) A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 46:5629–5632PubMed Senger DR, Perruzzi CA, Feder J, Dvorak HF (1986) A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 46:5629–5632PubMed
41.
Zurück zum Zitat Horowitz JR, Rivard A, van der Zee R, Hariawala M, Sheriff DD et al (1997) Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension: evidence for a maintenance role in quiescent adult endothelium. Arterioscler Thromb Vasc Biol 17:2793–2800CrossRefPubMed Horowitz JR, Rivard A, van der Zee R, Hariawala M, Sheriff DD et al (1997) Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension: evidence for a maintenance role in quiescent adult endothelium. Arterioscler Thromb Vasc Biol 17:2793–2800CrossRefPubMed
42.
Zurück zum Zitat Roberts WG, Palade GE (1995) Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 108(Pt 6):2369–2379PubMed Roberts WG, Palade GE (1995) Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 108(Pt 6):2369–2379PubMed
43.
Zurück zum Zitat Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V et al (1987) Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature 329:630–632CrossRefPubMed Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V et al (1987) Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature 329:630–632CrossRefPubMed
45.
Zurück zum Zitat Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF et al (1995) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62–66CrossRefPubMed Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF et al (1995) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62–66CrossRefPubMed
46.
Zurück zum Zitat Gerhardt H, Ruhrberg C, Abramsson A, Fujisawa H, Shima D et al (2004) Neuropilin-1 is required for endothelial tip cell guidance in the developing central nervous system. Dev Dyn 231:503–509CrossRefPubMed Gerhardt H, Ruhrberg C, Abramsson A, Fujisawa H, Shima D et al (2004) Neuropilin-1 is required for endothelial tip cell guidance in the developing central nervous system. Dev Dyn 231:503–509CrossRefPubMed
47.
Zurück zum Zitat Yoshiji H, Kuriyama S, Ways DK, Yoshii J, Miyamoto Y et al (1999) Protein kinase C lies on the signaling pathway for vascular endothelial growth factor-mediated tumor development and angiogenesis. Cancer Res 59:4413–4418PubMed Yoshiji H, Kuriyama S, Ways DK, Yoshii J, Miyamoto Y et al (1999) Protein kinase C lies on the signaling pathway for vascular endothelial growth factor-mediated tumor development and angiogenesis. Cancer Res 59:4413–4418PubMed
48.
Zurück zum Zitat Spyridopoulos I, Luedemann C, Chen D, Kearney M, Chen D et al (2002) Divergence of angiogenic and vascular permeability signaling by VEGF: inhibition of protein kinase C suppresses VEGF-induced angiogenesis, but promotes VEGF-induced, NO-dependent vascular permeability. Arterioscler Thromb Vasc Biol 22:901–906CrossRefPubMed Spyridopoulos I, Luedemann C, Chen D, Kearney M, Chen D et al (2002) Divergence of angiogenic and vascular permeability signaling by VEGF: inhibition of protein kinase C suppresses VEGF-induced angiogenesis, but promotes VEGF-induced, NO-dependent vascular permeability. Arterioscler Thromb Vasc Biol 22:901–906CrossRefPubMed
49.
Zurück zum Zitat Ulyatt C, Walker J, Ponnambalam S (2011) Hypoxia differentially regulates VEGFR1 and VEGFR2 levels and alters intracellular signaling and cell migration in endothelial cells. Biochem Biophys Res Commun 404:774–779CrossRefPubMed Ulyatt C, Walker J, Ponnambalam S (2011) Hypoxia differentially regulates VEGFR1 and VEGFR2 levels and alters intracellular signaling and cell migration in endothelial cells. Biochem Biophys Res Commun 404:774–779CrossRefPubMed
50.
Zurück zum Zitat Olszewska-Pazdrak B, Hein TW, Olszewska P, Carney DH (2009) Chronic hypoxia attenuates VEGF signaling and angiogenic responses by downregulation of KDR in human endothelial cells. Am J Physiol Cell Physiol 296:C1162–C1170CrossRefPubMed Olszewska-Pazdrak B, Hein TW, Olszewska P, Carney DH (2009) Chronic hypoxia attenuates VEGF signaling and angiogenic responses by downregulation of KDR in human endothelial cells. Am J Physiol Cell Physiol 296:C1162–C1170CrossRefPubMed
51.
Zurück zum Zitat Munaut C, Lorquet S, Pequeux C, Blacher S, Berndt S et al (2008) Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast. Hum Reprod 23:1407–1415CrossRefPubMed Munaut C, Lorquet S, Pequeux C, Blacher S, Berndt S et al (2008) Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast. Hum Reprod 23:1407–1415CrossRefPubMed
52.
Zurück zum Zitat Yamagishi S, Yonekura H, Yamamoto Y, Fujimori H, Sakurai S et al (1999) Vascular endothelial growth factor acts as a pericyte mitogen under hypoxic conditions. Lab Invest 79:501–509PubMed Yamagishi S, Yonekura H, Yamamoto Y, Fujimori H, Sakurai S et al (1999) Vascular endothelial growth factor acts as a pericyte mitogen under hypoxic conditions. Lab Invest 79:501–509PubMed
53.
Zurück zum Zitat Ito TK, Ishii G, Saito S, Yano K, Hoshino A et al (2009) Degradation of soluble VEGF receptor-1 by MMP-7 allows VEGF access to endothelial cells. Blood 113:2363–2369CrossRefPubMed Ito TK, Ishii G, Saito S, Yano K, Hoshino A et al (2009) Degradation of soluble VEGF receptor-1 by MMP-7 allows VEGF access to endothelial cells. Blood 113:2363–2369CrossRefPubMed
54.
Zurück zum Zitat Stapor P, Wang X, Goveia J, Moens S, Carmeliet P (2014) Angiogenesis revisited: role and therapeutic potential of targeting endothelial metabolism. J Cell Sci 127:4331–4341CrossRefPubMed Stapor P, Wang X, Goveia J, Moens S, Carmeliet P (2014) Angiogenesis revisited: role and therapeutic potential of targeting endothelial metabolism. J Cell Sci 127:4331–4341CrossRefPubMed
55.
Zurück zum Zitat Kroon ME, Koolwijk P, van der Vecht B, van Hinsbergh VW (2000) Urokinase receptor expression on human microvascular endothelial cells is increased by hypoxia: implications for capillary-like tube formation in a fibrin matrix. Blood 96:2775–2783PubMed Kroon ME, Koolwijk P, van der Vecht B, van Hinsbergh VW (2000) Urokinase receptor expression on human microvascular endothelial cells is increased by hypoxia: implications for capillary-like tube formation in a fibrin matrix. Blood 96:2775–2783PubMed
Metadaten
Titel
Hypoxia paradoxically inhibits the angiogenic response of isolated vessel explants while inducing overexpression of vascular endothelial growth factor
verfasst von
Alfred C. Aplin
Roberto F. Nicosia
Publikationsdatum
09.01.2016
Verlag
Springer Netherlands
Erschienen in
Angiogenesis / Ausgabe 2/2016
Print ISSN: 0969-6970
Elektronische ISSN: 1573-7209
DOI
https://doi.org/10.1007/s10456-015-9493-2

Weitere Artikel der Ausgabe 2/2016

Angiogenesis 2/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.